DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Indocin (Indomethacin) - Adverse Event Reports - Disability - Neonatal Respiratory Distress Syndrome

 



Index of reports > Cases resulting in disability (1) > Cases with Neonatal Respiratory Distress Syndrome (1)

Below is the selection of adverse event reports related to Indocin (Indomethacin) that includes cases resulting in disability where reactions include neonatal respiratory distress syndrome.

Adverse event in male receiving Indocin (Indomethacin)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-04-10

Patient: male, weighing 0.6 kg (1.4 pounds)

Adverse reactions / side effects: Hepatic Function Abnormal, Hyperbilirubinaemia, Drug Ineffective, Deafness, Jaundice Neonatal, C-Reactive Protein Increased, Developmental Delay, Catheter Sepsis, Abdominal Distension, Melaena, Neonatal Respiratory Distress Syndrome, Hyperglycaemia, Pancytopenia, Growth Retardation, Haemolysis, Renal Impairment, Psychomotor Skills Impaired

Adverse event resulted in: disablity

Suspect drug(s):
Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-01
    End date: 2006-03-01

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-03
    End date: 2006-03-03

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-04
    End date: 2006-03-04

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-06
    End date: 2006-03-06

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-20
    End date: 2006-03-20

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-22
    End date: 2006-03-22

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-24
    End date: 2006-03-24

Indocin
    Dosage: see image
    Indication: Patent Ductus Arteriosus
    Start date: 2006-03-27
    End date: 2006-03-27

Vancomycin Hydrochloride
    Dosage: 8 mg; qd; inj
    Indication: Infection
    Start date: 2006-03-12
    End date: 2006-03-22

Vancomycin Hydrochloride
    Dosage: 8 mg; qd; inj
    Indication: Sepsis
    Start date: 2006-03-12
    End date: 2006-03-22

Beractant (Beractant)
    Dosage: 1 dose; qd
    Indication: Neonatal Respiratory Distress Syndrome
    Start date: 2006-03-01
    End date: 2006-03-01

Beractant (Beractant)
    Dosage: 1 dose; qd
    Indication: Sepsis
    Start date: 2006-03-01
    End date: 2006-03-01

Humulin N
    Dosage: 0.12 u; qd; iv
    Indication: Hyperglycaemia
    Start date: 2006-03-16
    End date: 2006-03-20

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009